Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 15.15
Immunosuppression Use for Maintenance by Regimen
Two Years Following Transplantation, 1999 to 2007
Recipients with Heart-Lung Transplants
Transplant Year
1999
2000
2001
2002
2003
2004
2005
2006
2007
Transplants
51
48
27
33
29
40
35
31
31
Functioning Graft at 2 Years PostTx
22
26
18
18
12
29
24
16
24
With Maintenance Use Recorded at 2 Years PostTx
22
24
16
18
12
28
23
14
23
Tac
0.0%
4.2%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
4.3%
Tac + MMF/MPA
0.0%
4.2%
6.3%
0.0%
8.3%
0.0%
4.3%
0.0%
0.0%
--- + OtherAntimet
0.0%
4.2%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Tac + Siro/Evero
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
4.3%
0.0%
0.0%
CyA + Steroids
9.1%
8.3%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Tac + Steroids
0.0%
4.2%
25.0%
11.1%
0.0%
7.1%
13.0%
21.4%
30.4%
CyA + MMF/MPA + Steroids
9.1%
16.7%
6.3%
16.7%
8.3%
10.7%
8.7%
0.0%
8.7%
Tac + MMF/MPA + Steroids
31.8%
16.7%
37.5%
16.7%
41.7%
39.3%
39.1%
57.1%
43.5%
--- + OtherAntimet + Steroids
0.0%
0.0%
0.0%
5.6%
0.0%
3.6%
0.0%
0.0%
0.0%
CyA + OtherAntimet + Steroids
22.7%
8.3%
0.0%
11.1%
16.7%
7.1%
8.7%
0.0%
0.0%
Tac + OtherAntimet + Steroids
13.6%
20.8%
12.5%
16.7%
25.0%
21.4%
13.0%
14.3%
4.3%
--- + Siro/Evero + Steroids
0.0%
0.0%
0.0%
5.6%
0.0%
0.0%
0.0%
0.0%
0.0%
Tac + Siro/Evero + Steroids
9.1%
4.2%
12.5%
16.7%
0.0%
7.1%
4.3%
0.0%
0.0%
Other Regimen
4.5%
8.3%
0.0%
0.0%
0.0%
3.6%
4.3%
7.1%
8.7%
Source: OPTN/SRTR Data as of October 1, 2010.
Percentages are calculated based on the total number of patients with maintenance use at two years following transplantation. They sum to 100 percent for each column
---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.
MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.
"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.